Elevai Labs Stock (NASDAQ:ELAB)


RevenueFinancialsChart

Previous Close

$3.07

52W Range

$2.88 - $1.06K

50D Avg

$7.32

200D Avg

$191.77

Market Cap

$2.25M

Avg Vol (3M)

$587.13K

Beta

-1.24

Div Yield

-

ELAB Company Profile


Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

-

Website

-

ELAB Performance


ELAB Financial Summary


Dec 24Dec 23Dec 22
Revenue-$1.71M$766.28K
Operating Income$-4.02M$-3.67M$-1.79M
Net Income-$-4.30M$-1.80M
EBITDA$-4.02M$-4.27M$-1.78M
Basic EPS-$-0.40$-0.19
Diluted EPS-$-0.40$-0.19

Fiscal year ends in Dec 24 | Currency in USD